Baillie Gifford & Co »

Crispr Therapeutics shares owned by Baillie Gifford & Co

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Baillie Gifford & Co from 13F filings

Historical chart of Baillie Gifford & Co investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Baillie Gifford & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Baillie Gifford & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 423k 62.60
2023-09-30 $20M 441k 45.39
2023-06-30 $14M 244k 56.14
2023-03-31 $12M 263k 45.23
2022-12-31 $11M 263k 40.65
2022-09-30 $19M 289k 65.35